„Ægroti Salus Suprema Lex” −

The Benefit of the Patient is
the Highest Law

Since its beginning in early 2019, the ICPO Foundation has already received financial and active personal support from a growing community of internationally acclaimed experts, philanthropists, leading medical and industrial entities, and governmental institutions around the globe.

The ICPO Foundation is honored to be able to celebrate its official inauguration together with the 20th anniversary of Targeted Isotope Therapy in Bad Berka and would in this context like to extend an open invitation to all participants and the emerging international community in Precision Oncology to participate, contribute to, and benefit from its mission to globally expand and continously improve Best Practices and Patient Access in Precison Oncology.


The ICPO Foundation-Board of Trustees

Udo J. Vetter

Udo J. Vetter

Michael Lee-Chin

Michael Lee-Chin

Richard Baum

Prof. Dr. Richard P. Baum

Oliver Buck

Oliver Buck
The ICPO Foundation-Executive Management

Martin Bosch

Martin Bosch

Martin Reuter

Martin Reuter

Join the ICPO

and participate in making a paradigm shift in cancer treatment available to Patients worldwide

International Centers for Precision Oncology Foundation

Supporting Science and Technology Development

To support science and technology development in the field of Precision Oncology.

Formular erfolgreich abgesendet.